 | • レポートコード：MRC2312MG00175 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、62ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の遺伝子治療薬市場規模と予測を収録しています。・世界の遺伝子治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の遺伝子治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の遺伝子治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ウイルス遺伝子導入システム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 遺伝子治療薬のグローバル主要企業は、Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、遺伝子治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の遺伝子治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の遺伝子治療薬市場：タイプ別市場シェア、2022年 ・ウイルス遺伝子導入システム、非ウイルス遺伝子導入システム 世界の遺伝子治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の遺伝子治療薬市場：用途別市場シェア、2022年 ・神経疾患、癌、その他 世界の遺伝子治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の遺伝子治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における遺伝子治療薬のグローバル売上、2018年-2023年 ・主要企業における遺伝子治療薬のグローバル売上シェア、2022年 ・主要企業における遺伝子治療薬のグローバル販売量、2018年-2023年 ・主要企業における遺伝子治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Institute ************************************************************* ・調査・分析レポートの概要 遺伝子治療薬市場の定義 市場セグメント 世界の遺伝子治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の遺伝子治療薬市場規模 世界の遺伝子治療薬市場規模：2022年 VS 2029年 世界の遺伝子治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの遺伝子治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の遺伝子治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ウイルス遺伝子導入システム、非ウイルス遺伝子導入システム 遺伝子治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：神経疾患、癌、その他 遺伝子治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別遺伝子治療薬市場規模 2022年と2029年 地域別遺伝子治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Institute ... |
This research report provides a comprehensive analysis of the Gene-based Therapy Medicinal market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Gene-based Therapy Medicinal market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Gene-based Therapy Medicinal, challenges faced by the industry, and potential opportunities for market players.
The global Gene-based Therapy Medicinal market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Gene-based Therapy Medicinal market presents opportunities for various stakeholders, including Neurological Diseases, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Gene-based Therapy Medicinal market. Additionally, the growing consumer demand present avenues for market expansion.
The global Gene-based Therapy Medicinal market was valued at US$ 8548.6 million in 2022 and is projected to reach US$ 46680 million by 2029, at a CAGR of 27.4% during the forecast period.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
Key Features:
The research report on the Gene-based Therapy Medicinal market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Gene-based Therapy Medicinal market.
Market Overview: The report provides a comprehensive overview of the Gene-based Therapy Medicinal market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Gene-based Therapy Medicinal market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Gene-based Therapy Medicinal market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Gene-based Therapy Medicinal market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Gene-based Therapy Medicinal market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Gene-based Therapy Medicinal market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Gene-based Therapy Medicinal market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Gene-based Therapy Medicinal, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Gene-based Therapy Medicinal market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Gene-based Therapy Medicinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segment by Application
Neurological Diseases
Cancer
Other
Global Gene-based Therapy Medicinal Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene-based Therapy Medicinal, market overview.
Chapter 2: Global Gene-based Therapy Medicinal market size in revenue.
Chapter 3: Detailed analysis of Gene-based Therapy Medicinal company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene-based Therapy Medicinal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Gene-based Therapy Medicinal Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-based Therapy Medicinal Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-based Therapy Medicinal Overall Market Size
2.1 Global Gene-based Therapy Medicinal Market Size: 2022 VS 2029
2.2 Global Gene-based Therapy Medicinal Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-based Therapy Medicinal Players in Global Market
3.2 Top Global Gene-based Therapy Medicinal Companies Ranked by Revenue
3.3 Global Gene-based Therapy Medicinal Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Therapy Medicinal Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene-based Therapy Medicinal Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Therapy Medicinal Players in Global Market
3.6.1 List of Global Tier 1 Gene-based Therapy Medicinal Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-based Therapy Medicinal Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Gene-based Therapy Medicinal Market Size Markets, 2022 & 2029
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type – Global Gene-based Therapy Medicinal Revenue & Forecasts
4.2.1 By Type – Global Gene-based Therapy Medicinal Revenue, 2018-2023
4.2.2 By Type – Global Gene-based Therapy Medicinal Revenue, 2024-2029
4.2.3 By Type – Global Gene-based Therapy Medicinal Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gene-based Therapy Medicinal Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application – Global Gene-based Therapy Medicinal Revenue & Forecasts
5.2.1 By Application – Global Gene-based Therapy Medicinal Revenue, 2018-2023
5.2.2 By Application – Global Gene-based Therapy Medicinal Revenue, 2024-2029
5.2.3 By Application – Global Gene-based Therapy Medicinal Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Gene-based Therapy Medicinal Market Size, 2022 & 2029
6.2 By Region – Global Gene-based Therapy Medicinal Revenue & Forecasts
6.2.1 By Region – Global Gene-based Therapy Medicinal Revenue, 2018-2023
6.2.2 By Region – Global Gene-based Therapy Medicinal Revenue, 2024-2029
6.2.3 By Region – Global Gene-based Therapy Medicinal Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Gene-based Therapy Medicinal Revenue, 2018-2029
6.3.2 US Gene-based Therapy Medicinal Market Size, 2018-2029
6.3.3 Canada Gene-based Therapy Medicinal Market Size, 2018-2029
6.3.4 Mexico Gene-based Therapy Medicinal Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Gene-based Therapy Medicinal Revenue, 2018-2029
6.4.2 Germany Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.3 France Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.4 U.K. Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.5 Italy Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.6 Russia Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.7 Nordic Countries Gene-based Therapy Medicinal Market Size, 2018-2029
6.4.8 Benelux Gene-based Therapy Medicinal Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Gene-based Therapy Medicinal Revenue, 2018-2029
6.5.2 China Gene-based Therapy Medicinal Market Size, 2018-2029
6.5.3 Japan Gene-based Therapy Medicinal Market Size, 2018-2029
6.5.4 South Korea Gene-based Therapy Medicinal Market Size, 2018-2029
6.5.5 Southeast Asia Gene-based Therapy Medicinal Market Size, 2018-2029
6.5.6 India Gene-based Therapy Medicinal Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Gene-based Therapy Medicinal Revenue, 2018-2029
6.6.2 Brazil Gene-based Therapy Medicinal Market Size, 2018-2029
6.6.3 Argentina Gene-based Therapy Medicinal Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Gene-based Therapy Medicinal Revenue, 2018-2029
6.7.2 Turkey Gene-based Therapy Medicinal Market Size, 2018-2029
6.7.3 Israel Gene-based Therapy Medicinal Market Size, 2018-2029
6.7.4 Saudi Arabia Gene-based Therapy Medicinal Market Size, 2018-2029
6.7.5 UAE Gene-based Therapy Medicinal Market Size, 2018-2029
7 Gene-based Therapy Medicinal Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene-based Therapy Medicinal Major Product Offerings
7.1.4 Biogen Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene-based Therapy Medicinal Major Product Offerings
7.2.4 Novartis Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene-based Therapy Medicinal Major Product Offerings
7.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Major Product Offerings
7.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News & Latest Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene-based Therapy Medicinal Major Product Offerings
7.6.4 Amgen Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene-based Therapy Medicinal Major Product Offerings
7.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Major Product Offerings
7.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News & Latest Developments
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene-based Therapy Medicinal Major Product Offerings
7.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.9.5 Sunway Biotech Key News & Latest Developments
7.10 SIBIONO
7.10.1 SIBIONO Company Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene-based Therapy Medicinal Major Product Offerings
7.10.4 SIBIONO Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.10.5 SIBIONO Key News & Latest Developments
7.11 AnGes
7.11.1 AnGes Company Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene-based Therapy Medicinal Major Product Offerings
7.11.4 AnGes Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.11.5 AnGes Key News & Latest Developments
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Major Product Offerings
7.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Major Product Offerings
7.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue in Global Market (2018-2023)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer